Search Results - "Kovarik, M."

Refine Results
  1. 1

    Mu-opioid receptor inhibition decreases voluntary wheel running in a dopamine-dependent manner in rats bred for high voluntary running by Ruegsegger, Gregory N, Brown, Jacob D, Cathleen Kovarik, M, Miller, Dennis K, Booth, Frank W

    Published in Neuroscience (17-12-2016)
    “…Highlights • Intrinsic Oprm1 function was increased in the NAc of HVR compared to LVR rats. • Intraperitoneal naltrexone reduced dopamine-related mRNAs,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues by Holecek, M., Muthny, T., Kovarik, M., Sispera, L.

    Published in Food and chemical toxicology (2009)
    “…Beta-hydroxy-beta-methylbutyrate (HMB) is a leucine metabolite with protein anabolic effect. The aim of the study was to examine the role of exogenous HMB on…”
    Get full text
    Journal Article
  5. 5

    Critical evaluation of muscle mass loss as a prognostic marker of morbidity in critically ill patients and methods for its determination by Joskova, Vera, Patkova, Anna, Havel, Eduard, Najpaverova, Simona, Uramova, Daniela, Kovarik, Miroslav, Zadak, Zdenek, Hronek, Miloslav

    “…Loss of muscle mass in critically ill patients is associated with serious consequences, such as prolonged mechanical ventilation, intensive care unit…”
    Get full text
    Journal Article
  6. 6

    Estradiol directly attenuates sodium currents and depolarizing afterpotentials in isolated gonadotropin-releasing hormone neurons by Wang, Yong, Kuehl-Kovarik, M. Cathleen

    Published in Brain research (03-02-2012)
    “…Abstract The gonadotropin-releasing hormone (GnRH) neuron is the pivotal control center in a tightly regulated reproductive axis. The release of GnRH controls…”
    Get full text
    Journal Article
  7. 7

    The bioimpedance spectroscopy as useful tool for measuring the fluid excess and fluid management in severe polytrauma patients by Joskova, V., Patkova, A., Havel, E., Najpaverova, S., Uramova, D., Kovarik, M., Zadak, Z., Hronek, M.

    Published in Physiological research (01-01-2019)
    “…Although the fluid therapy plays a fundamental role in the management of polytrauma patients (PP), a tool which could determine it appropriately is still…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Multiple-Dose FTY720: Tolerability, Pharmacokinetics, and Lymphocyte Responses in Healthy Subjects by Kovarik, John M., Schmouder, Robert, Barilla, Denise, Riviere, Gilles-Jacques, Wang, Yibin, Hunt, Thomas

    Published in Journal of clinical pharmacology (01-05-2004)
    “…FTY720 is a sphingosine‐1‐phosphate receptor agonist being developed as an immunomodulator for acute rejection prophylaxis after organ transplantation. This…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Hand grip endurance test relates to clinical state and prognosis in COPD patients better than 6-minute walk test distance by Kovarik, Miroslav, Joskova, Vera, Patkova, Anna, Koblizek, Vladimir, Zadak, Zdenek, Hronek, Miloslav

    “…Patients with COPD present peripheral muscle dysfunction and atrophy, expressed as muscle strength and endurance reduction. The goal of this study was direct…”
    Get full text
    Journal Article
  14. 14

    Estradiol attenuates multiple tetrodotoxin-sensitive sodium currents in isolated gonadotropin-releasing hormone neurons by Wang, Yong, Garro, Mona, Kuehl-Kovarik, M. Cathleen

    Published in Brain research (23-07-2010)
    “…Abstract Secretion from gonadotropin-releasing hormone (GnRH) neurons is necessary for the production of gametes and hormones from the gonads. Subsequently,…”
    Get full text
    Journal Article
  15. 15

    Exposure-response relationships for everolimus in de novo kidney transplantation: Defining a therapeutic range by KOVARIK, John M, KAPLAN, Bruce, SILVA, Hélio Tedesco, KAHAN, Barry D, DANTAL, Jacque, VITKO, Stefan, BOGER, Robert, RORDORF, Christiane

    Published in Transplantation (27-03-2002)
    “…Exposure, safety, and efficacy data from the two everolimus randomized, double-blind phase 3 trials were evaluated to identify a therapeutic concentration…”
    Get full text
    Journal Article
  16. 16

    Single‐dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects by Kovarik, John M., Schmouder, Robert, Barilla, Denise, Wang, Yibin, Kraus, Gerolf

    Published in British journal of clinical pharmacology (01-05-2004)
    “…Aims FTY720 is a sphingosine‐1‐phosphate receptor agonist that redirects lymphocytes from the circulation to lymph nodes without impairing lymphocyte function…”
    Get full text
    Journal Article
  17. 17

    Pharmacokinetic interaction between verapamil and everolimus in healthy subjects by Kovarik, J. M., Beyer, D., Bizot, M. N., Jiang, Q., Allison, M. J., Schmouder, R. L.

    Published in British journal of clinical pharmacology (01-10-2005)
    “…Aims We sought to define the influence of verapamil, an inhibitor of CYP3A and P‐glycoprotein, on the pharmacokinetics of everolimus, a substrate of this…”
    Get full text
    Journal Article
  18. 18

    Blood Concentrations of Everolimus Are Markedly Increased by Ketoconazole by Kovarik, J. M., Beyer, D., Bizot, M. N., Jiang, Q., Shenouda, M., Schmouder, R. L.

    Published in Journal of clinical pharmacology (01-05-2005)
    “…The authors sought to quantify the influence of the CYP3A and P‐glycoprotein inhibitor ketoconazole on the pharmacokinetics of everolimus in healthy subjects…”
    Get full text
    Journal Article
  19. 19

    Flufenamic acid modulates multiple currents in gonadotropin-releasing hormone neurons by Wang, Yong, Kuehl-Kovarik, M. Cathleen

    Published in Brain research (24-09-2010)
    “…Abstract Reproduction in mammals is dependent upon the appropriate neurosecretion of gonadotropin-releasing hormone (GnRH), yet the endogenous generation of…”
    Get full text
    Journal Article
  20. 20

    Therapeutic Drug Monitoring for Everolimus in Heart Transplant Recipients Based on Exposure–Effect Modeling by Starling, Randall C., Hare, Joshua M., Hauptman, Paul, McCurry, Kenneth R., Mayer, Hartmut W., Kovarik, John M., Schmidli, Heinz

    Published in American journal of transplantation (01-12-2004)
    “…Everolimus, a proliferation signal inhibitor, is an immunosuppressant that targets the primary causes of progressive allograft dysfunction, thus improving the…”
    Get full text
    Journal Article